RedHill Biopharma Announces U.S. Commercial Launch of Talicia® for H. pylori Infection

    NEXT STORY
    New Clinical Trial Exploring Revolution Medicines’ Investigational SHP2 Inhibitor RMC-4630 in Combination with an ERK Inhibitor Announced by Netherlands Cancer Institute
    PREV STORY
    Global Endoscope Market by Type, Application, End-user and Geography – Forecast to 2024
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Sabin Vaccine Institute Appoints Filip Dubovsky to Board of Trustees

    author_avatar
    NASDAQ Market News

    TYME and The Joseph Ahmed Foundation Announce Initiation of the HopES Phase II Trial Evaluating the Potential Benefits of SM-88 for Patients with High-Risk Sarcomas

    author_avatar
    NASDAQ Market News

    Merus annonce les résultats financiers du troisième trimestre 2018 et fait le point sur son activité

    Jalons cliniques des quatre principaux programmes Biclonics® prévus en 2019Les liquidités devraient être suffisantes ...

    author_avatar
    NASDAQ Market News